# Phase 60 — Evidence sufficiency decision

**NO-GO: insufficient source-verified data for further factor-conditioned profitability testing.**

- Phase 52: 1/480 rows executed under the frozen 2% OHLC range proxy.
- Phase 54: eligibility rose from 1/480 at 2% to 380/480 at the 1000% diagnostic threshold; this is coverage only.
- Phase 56: 18,960 modeled scenarios; five configuration-threshold pairs passed the severe-cost screen only at 1000%.
- Phase 57: 2,286 common scenarios reproduced with zero mismatches.
- Phase 59: 10 candidates; zero accepted free/license-clear exact prior-minute OI sources and zero accepted exact quote/depth sources.

## What this does and does not establish

- The OHLC reference model is reproducible under the pinned inputs and modeled cost scenarios.
- A reproducible OHLC model is not proof of bid/ask executable fills or live profitability.
- Relaxing the 2% candle-range gate mechanically increases eligible rows; the 1000% diagnostic endpoint is not a trading recommendation.
- The baseline has only one passing row, so no meaningful factor-selector efficacy or strategy ranking is supported.
- No holdout was used; no strategy or factor selector was promoted.

## Restart condition

1. Document explicit license, automated access, caching/storage and derived-result publication rights, or find a new source with clear rights.
2. Verify a small exact target-date/contract sample at 09:44, 09:45, 12:59, 13:00 and 15:15 IST, with actual expiry, strike and CE/PE identity.
3. Do not coerce missing OI to zero; preserve source values and distinguish missing, true zero, duplicate and conflicting rows.
4. For execution-quality claims, verify historical bid price, ask price, bid quantity and ask quantity at required entry/exit times; OHLC/LTP is not a substitute.
5. Demonstrate enough eligible development/validation events before inferential comparison; holdout stays untouched.
6. Recalculate Paytm Money brokerage, statutory charges, adverse slippage and stress cases only after valid coverage is proven.

## Final decision

The current data supports reproducibility and eligibility-coverage diagnostics, not a defensible profitability conclusion for factor-conditioned option strategy selection. No candidate is promoted.
